Access the full text.
Sign up today, get DeepDyve free for 14 days.
Yasuhiro Hirasawa, A. Nakagomi, Yoshinori Kobayashi, T. Katoh, K. Mizuno (2009)
Short-term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia.Circulation journal : official journal of the Japanese Circulation Society, 73 4
David Hamilton, Shuktika Nandkeolyar, H. Lan, Pooja Desai, J. Evans, Christopher Hauschild, Dimpa Choksi, I. Abudayyeh, T. Contractor, Anthony Hilliard (2020)
Amiodarone: A Comprehensive Guide for CliniciansAmerican Journal of Cardiovascular Drugs
A. Carpenter, Owen Chambers, A. Harchi, Richard Bond, O. Hanington, S. Harmer, J. Hancox, A. James (2020)
COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2Frontiers in Cardiovascular Medicine, 7
E. Chorin, Matthew Dai, E. Shulman, L. Wadhwani, R. Cohen, Chirag Barbhaiya, A. Aizer, Douglas Holmes, S. Bernstein, Michael Soinelli, David Park, L. Chinitz, L. Jankelosn (2020)
The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/AzithromycinmedRxiv
R. Megens, S. Vijayan, D. Lievens, Y. Döring, M. Zandvoort, J. Grommes, C. Weber, O. Soehnlein (2012)
Presence of luminal neutrophil extracellular traps in atherosclerosisThrombosis and Haemostasis, 107
Sangeun Jeon, Meehyun Ko, Jihye Lee, Inhee Choi, S. Byun, Soonju Park, David Shum, Seungtaek Kim (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved DrugsAntimicrobial Agents and Chemotherapy, 64
Naidi Yang, Han-Ming Shen (2020)
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19International Journal of Biological Sciences, 16
K. Stadler, H. Ha, V. Ciminale, C. Spirli, G. Saletti, M. Schiavon, D. Bruttomesso, L. Bigler, F. Follath, A. Pettenazzo, A. Baritussio (2008)
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.American journal of respiratory cell and molecular biology, 39 2
G. Lippi, F. Sanchis-Gomar, B. Henry (2020)
COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weaponAnnals of Translational Medicine, 8
A. Wong, L. Fidler, V. Marcoux, K. Johannson, D. Assayag, J. Fisher, N. Hambly, M. Kolb, J. Morisset, S. Shapera, C. Ryerson (2020)
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 PandemicChest, 158
T. Ide, H. Tsutsui, S. Kinugawa, H. Utsumi, A. Takeshita (1999)
Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action.Circulation, 100 7
Anil Gehi, D. Mehta, J. Gomes (2006)
Evaluation and management of patients after implantable cardioverter-defibrillator shock.JAMA, 296 23
C. Salata, A. Baritussio, Denis Munegato, A. Calistri, H. Ha, L. Bigler, F. Fabris, C. Parolin, G. Palù, A. Mirazimi (2015)
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry processPathogens and Disease, 73
Haruyasu Ito, K. Ono, R. Nishio, S. Sasayama, A. Matsumori (2002)
Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.Cytokine, 17 4
Z. Halıcı, G. Dengiz, F. Odabasoglu, H. Suleyman, E. Çadırcı, M. Halici (2007)
Amiodarone has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced paw edema.European journal of pharmacology, 566 1-3
C. Salata, Denis Munegato, E. Piccoli, A. Calistri, C. Parolin, A. Mirazimi, A. Baritussio, G. Palù (2016)
Amiodarone increases positive-strand RNA virus replication in vitro: implications for its use in patients with viral infections.The Journal of antimicrobial chemotherapy, 71 1
H. Nakaya (2009)
Does anti-inflammatory action of amiodarone explain the high efficacy in patients with heart failure?Circulation journal : official journal of the Japanese Circulation Society, 73 4
A. Aimo, A. Baritussio, M. Emdin, C. Tascini (2020)
Amiodarone as a possible therapy for coronavirus infection.European journal of preventive cardiology
J. Heijman, D. Dobrev (2013)
Pleiotropic actions of amiodarone: still puzzling after half a centuryNaunyn-Schmiedeberg's Archives of Pharmacology, 386
B. Polat, E. Çadırcı, Z. Halıcı, Y. Bayir, D. Unal, B. Bilgin, T. Yuksel, S. Vançelik (2013)
The protective effect of amiodarone in lung tissue of cecal ligation and puncture-induced septic rats: a perspective from inflammatory cytokine release and oxidative stressNaunyn-Schmiedeberg's Archives of Pharmacology, 386
L. Karnatovskaia, E. Festic, O. Gajic, R. Carter, Augustine Lee (2012)
Prehospital amiodarone may increase the incidence of acute respiratory distress syndrome among patients at risk.Journal of critical care, 27 5
H. Oral, S. Fisher, W. Fay, S. Singh, R. Fletcher, F. Morady (1999)
Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.The American journal of cardiology, 83 3
S. Kochav, E. Coromilas, Ani Nalbandian, Lauren Ranard, Aakriti Gupta, M. Chung, R. Gopinathannair, A. Biviano, H. Garan, E. Wan (2020)
Cardiac Arrhythmias in COVID-19 InfectionCirculation. Arrhythmia and Electrophysiology, 13
Petter Andersen, Aleksandr Ianevski, H. Lysvand, A. Vitkauskienė, Valentyn Oksenych, M. Bjørås, K. Telling, I. Lutsar, U. Dumpis, Y. Irie, T. Tenson, A. Kantele, D. Kainov (2019)
Discovery and development of safe-in-man broad-spectrum antiviral agentsInternational Journal of Infectious Diseases, 93
O. Kadioglu, M. Saeed, H. Greten, T. Efferth (2020)
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learningComputers in Biology and Medicine, 133
Akira Matsumori, Koh Ono, R. Nishio, Yoshisuke Nose, S. Sasayama (1997)
Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure.Circulation, 96 5
A. Rali, Andrew Sauer (2020)
COVID-19 Pandemic and Cardiovascular DiseaseUS Cardiology Review
Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present the rationale of using amiodarone in the COVID-19 scenario, as well as whether or not amiodarone administration represents a potential strategy to prevent SARS-CoV-2 infection, rather than simply used to treat patients already symptomatic and/or with severe coronavirus disease 2019 (COVID-19), based on current evidence.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Oct 1, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.